Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME   >  CORPORATE INFO >  BOARD MEETINGS
Board Meetings      
Shringar House of Mangalsutra Ltd.
Source DateBoard Meeting DateDetails
06-Nov-2025 12-Nov-2025 544512 | Board Meeting Intimation for To Inter-Alia Consider And Approve, The Unaudited Financial Results Of The Company For The Quarter And Half Year Ended September 30, 2025. Board Meeting 0.26 MB XBRLShringar House Of Mangalsutra Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2025 ,inter alia, to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that a meeting of the Board of Directors of Shringar House of Mangalsutra Limited (the Company) is scheduled to be held on Wednesday, November 12, 2025, to inter-alia consider and approve, the Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2025. In accordance with the SEBI (Prohibition of Insider Trading) Regulations, 2015 and in terms of the Companys Code of Conduct for Regulating, Monitoring and Reporting of Trading by Insiders of the Company, we have intimated about the closure of Trading Window vide our letter dated September 29, 2025. The Trading Window shall continue to remain closed till 48 hours from the announcement of the financial results of the Company for the quarter and half year ended September 30, 2025. This intimation is also being uploaded on the Companys website at www.shringar.
26-Sep-2025 07-Oct-2025 Quarterly Results
Page 1 of 1
Prev || Next
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Smart ODR Portal | Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.